Literature DB >> 15245741

Mechanisms of HIV-1 escape from immune responses and antiretroviral drugs.

Justin Bailey1, Joel N Blankson, Megan Wind-Rotolo, Robert F Siliciano.   

Abstract

Despite the fact that HIV-1 induces vigorous antiviral immune responses, viral replication is never completely controlled in infected individuals. Recent studies have provided insight into the mechanisms by which focused immune pressure directed at particular B or T cell epitopes leads to the rapid appearance of escape mutations. Even if anti-HIV-1 immune responses could be enhanced to the point where they inhibit viral replication to the same extent as certain combinations of antiretroviral drugs, eradication would be unlikely because of the persistence of the virus in an extremely stable latent reservoir in resting memory CD4(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245741     DOI: 10.1016/j.coi.2004.05.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  22 in total

Review 1.  HIV latency.

Authors:  Robert F Siliciano; Warner C Greene
Journal:  Cold Spring Harb Perspect Med       Date:  2011-09       Impact factor: 6.915

2.  The antigenic determinants on HIV p24 for CD4+ T cell inhibiting antibodies as determined by limited proteolysis, chemical modification, and mass spectrometry.

Authors:  Jason G Williams; Kenneth B Tomer; Catarina E Hioe; Susan Zolla-Pazner; Philip J Norris
Journal:  J Am Soc Mass Spectrom       Date:  2006-07-27       Impact factor: 3.109

3.  Simian immunodeficiency virus variants that differ in pathogenicity differ in fitness under rapid cell turnover conditions.

Authors:  Yegor Voronin; Julie Overbaugh; Michael Emerman
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

4.  A mathematical model of HIV dynamics in the presence of a rescuing virus with replication deficiency.

Authors:  Elias Zintzaras; Axel Kowald
Journal:  Theory Biosci       Date:  2011-01-29       Impact factor: 1.919

Review 5.  New paradigms for HIV/AIDS vaccine development.

Authors:  Louis J Picker; Scott G Hansen; Jeffrey D Lifson
Journal:  Annu Rev Med       Date:  2011-09-19       Impact factor: 13.739

6.  Different mechanisms of antibody-mediated neutralization of parvoviruses revealed using the Fab fragments of monoclonal antibodies.

Authors:  Christian D S Nelson; Laura M Palermo; Susan L Hafenstein; Colin R Parrish
Journal:  Virology       Date:  2007-01-09       Impact factor: 3.616

7.  HIV-1 neutralizing antibody response and viral genetic diversity characterized with next generation sequencing.

Authors:  Christoph C Carter; Gabriel A Wagner; George K Hightower; Gemma Caballero; Pham Phung; Douglas D Richman; Sergei L Kosakovsky Pond; Davey M Smith
Journal:  Virology       Date:  2014-11-11       Impact factor: 3.616

8.  Lymphocytic choriomeningitis virus infection yields overlapping CD4+ and CD8+ T-cell responses.

Authors:  Courtney Dow; Carla Oseroff; Bjoern Peters; Courtney Nance-Sotelo; John Sidney; Michael Buchmeier; Alessandro Sette; Bianca R Mothé
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

9.  Granzyme H destroys the function of critical adenoviral proteins required for viral DNA replication and granzyme B inhibition.

Authors:  Felipe Andrade; Edward Fellows; Dieter E Jenne; Antony Rosen; C S H Young
Journal:  EMBO J       Date:  2007-03-15       Impact factor: 11.598

10.  CD4(+) T-cell inhibitory ligands: a tool for characterizing dysfunctional CD4(+) T cells during chronic infection.

Authors:  Courtney Dow; Ryan Henderson; Alessandro Sette; Bianca R Mothé
Journal:  Immunology       Date:  2013-09       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.